Susquehanna International Group
RVPHW

Susquehanna International Group’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Susquehanna International Group’s Portfolio RVPHW Stock Details RVPHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-134,668
Closed -$10.8K – 13434
2025
Q3 		$10.8K Buy
134,668
+119,467
+786% +$5.33K ﹤0.01% 12093
2025
Q2 		$489 Buy
+15,201
New +$828 ﹤0.01% 12526
2022
Q3 		– Sell
-57,064
Closed -$10K – 13988
2022
Q2 		$10K Buy
+57,064
New +$11.5K ﹤0.01% 12507

Susquehanna International Group's RVPHW Position: Q4 2025 in Review

Susquehanna International Group sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q4 2025, closing a stake of 134,668 shares — an estimated $10.8K sold.

Susquehanna International Group first reported a position in RVPHW in Q2 2022 and held it in 3 quarters. The position peaked at $10.8K in Q3 2025. 0 funds tracked by Wall St. Rank hold RVPHW as of Q4 2025.

  • Susquehanna International Group reported no remaining Reviva Pharmaceuticals Warrants position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 134,668 Reviva Pharmaceuticals Warrants shares in Q4 2025, an estimated $10.8K.
  • Susquehanna International Group first reported a position in Reviva Pharmaceuticals Warrants in Q2 2022 and held it in 3 quarters.
  • Susquehanna International Group's Reviva Pharmaceuticals Warrants position peaked at $10.8K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.